Overview of Dr. Pyo
Robert Pyo, MD is a cardiologist specializing in interventional cardiology and peripheral endovascular interventional cardiology based in Stony Brook, NY. MD Pyo completed his education at the University of Illinois College of Medicine, before carrying out his residency and fellowships at the Icahn School of Medicine at Mount Sinai/Mount Sinai Hospital. MD Pyo has held the position of Medical Director at Stony Brook University Hospital since 2017 and has been the Associate Director of the Cardiac Catheterization Laboratory at Montefiore Medical Center since 2014. His areas of expertise include general cardiology, hypertension, coronary artery disease, valvular heart disease, and cardiac catheterization. MD Pyo is a published author on cardiology topics and has participated in clinical trials, including the SHIELD II Clinical Investigation.
Office
Stony Brook University Hospital
Health Sciences Tower, Level 16 Rm 080
Stony Brook, NY 11794Fax+1 631-444-1054
Education & Training
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Interventional Cardiology, 2006 - 2007
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Cardiovascular Disease, 2001 - 2006
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1999 - 2001
- University of Illinois College of MedicineClass of 1996
Certifications & Licensure
- NY State Medical License 2001 - 2025
- LA State Medical License 2018 - 2019
- NJ State Medical License 2013 - 2015
Clinical Trials
- SHIELD II Clinical Investigation Start of enrollment: 2015 Aug 01
Publications & Presentations
PubMed
- 13 citationsIntracoronary optical coherence tomography: Clinical and research applications and intravascular imaging software overview.Erhan Tenekecioglu, Felipe N. Albuquerque, Yohei Sotomi, Yaping Zeng, Pannipa Suwannasom
Catheterization and Cardiovascular Interventions. 2017-03-01 - 208 citationsImpact of the Everolimus-Eluting Stent on Stent Thrombosis: A Meta-Analysis of 13 Randomized TrialsUsman Baber, Roxana Mehran, Samin K. Sharma, Somjot S Brar, Jennifer Yu
Journal of the American College of Cardiology. 2011-10-04 - 649 citationsTargeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysmsRobert Pyo, Jason K. Lee, J. Michael Shipley, John A. Curci, Dongli Mao
The Journal of Clinical Investigation. 2000-06-01
Authored Content
- Does FFR-Guided Complete Revascularization in ACS Lead to Better Outcomes?September 2024
Press Mentions
- Vivasure Medical Announces First Patient Treated in U.S. Early Feasibility Study Evaluating PerQseal+March 31st, 2022
- Radial Access Doubled for Left Main PCI in the UK Between 2007 and 2014September 21st, 2018
- Heart Institute Uses Groundbreaking Technology to Treat High Blood PressureJanuary 26th, 2024
Professional Memberships
- Member
Other Languages
- Korean
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
First Health PPO
GHI PPO
Great West PPO
Healthfirst New YorkHIP of New York - Select PPO
Humana ChoiceCare Network PPO
MagnaCare PPO
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare HMO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: